Literature DB >> 6152389

Trichloroethylene effects on the formation of enzyme-altered foci in rat liver.

M M Milks, D Couri.   

Abstract

The initiating and promoting effects of trichloroethylene in rat liver were investigated using the enzyme-altered foci bioassay. The incidence of gamma-glutamyl transpeptidase (GGT)-positive foci was used as an early histochemical marker of putative preneoplastic hepatocytes. A single PO dose of trichloroethylene (490 mg/kg) was administered in corn oil to rats which had been partially hepatectomized 24 h previously. Three days following gavage with the chlorinated hydrocarbon the rats were promoted with an 8-week regimen of 500 ppm phenobarbital in drinking water. This protocol is known to induce enzyme-altered foci in the livers of animals which have received an initiating dose of a genotoxic carcinogen. Trichloroethylene was not found to induce GGT-positive foci under these conditions. Additionally, groups of rats were partially hepatectomized, initiated with N-nitrosodiethylamine (30 mg/kg; PO) and administered five times weekly doses of 200 mg trichloroethylene per rat in order to investigate the promoting activity of the chlorinated hydrocarbon in rat liver. No significant promoter effects were observed with trichloroethylene, although the results in this case were somewhat equivocal. The findings of these investigations are taken as partially supportive of an epigenetic, cytotoxic mechanism of tumorigenic action of trichloroethylene.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6152389     DOI: 10.1007/BF00349073

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  29 in total

1.  Mutagenicity in vitro and potential carcinogenicity of chlorinated ethylenes as a function of metabolic oxiran formation.

Authors:  H Greim; G Bonse; Z Radwan; D Reichert; D Henschler
Journal:  Biochem Pharmacol       Date:  1975-11-01       Impact factor: 5.858

2.  Background information on trichloroethylene.

Authors:  J W Lloyd; R M Moore; P Breslin
Journal:  J Occup Med       Date:  1975-09

3.  Enhancement of the metabolism and hepatotoxicity of trichloroethylene and perchloroethylene.

Authors:  M T Moslen; E S Reynolds; S Szabo
Journal:  Biochem Pharmacol       Date:  1977-03-01       Impact factor: 5.858

4.  [IARC monographs on the evaluation of the carcinogenic risk of chemicals to man: cadmium, nickel, some epoxides, miscellaneous industrial chemicals and general consideration on volatile anaesthetics].

Authors: 
Journal:  IARC Monogr Eval Carcinog Risk Chem Man       Date:  1976

5.  The pharmacokinetics and macromolecular interactions of trichloroethylene in mice and rats.

Authors:  W T Stott; J F Quast; P G Watanabe
Journal:  Toxicol Appl Pharmacol       Date:  1982-01       Impact factor: 4.219

6.  Metabolic activation and hepatotoxicity of trichloroethylene.

Authors:  E S Reynolds; M T Moslen
Journal:  Adv Exp Med Biol       Date:  1981       Impact factor: 2.622

7.  Tissue-mediated mutagenicity of vinylidene chloride in Salmonella typhimurium TA1535.

Authors:  B K Jones; D E Hathway
Journal:  Cancer Lett       Date:  1978-07       Impact factor: 8.679

8.  Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis.

Authors:  D B Solt; A Medline; E Farber
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

9.  Carcinogenicity study of trichloroethylene by longterm inhalation in three animal species.

Authors:  D Henschler; W Romen; H M Elsässer; D Reichert; E Eder; Z Radwan
Journal:  Arch Toxicol       Date:  1980-02       Impact factor: 5.153

10.  Metabolism and mutagenicity of halogenated olefins--a comparison of structure and activity.

Authors:  D Henschler
Journal:  Environ Health Perspect       Date:  1977-12       Impact factor: 9.031

View more
  1 in total

Review 1.  Enzymes of glutathione metabolism as biochemical markers during hepatocarcinogenesis.

Authors:  S Hendrich; H C Pitot
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.